An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease

An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease

There is a clinical need for new, more effective treatments for chronic and debilitating inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Targeting drugs selectively to the inflamed intestine may improve therapeutic outcomes and minimize systemic toxicity. We...

Full description

Bibliographic Details
Main Authors: Ermann, J. (Author), Zhou, A. (Author), Hamilton, M. J. (Author), Cao, B. (Author), Korzenik, J. R. (Author), Glickman, J. N. (Author), Vemula, P. K. (Author), Glimcher, L. H. (Author), Zhang, Sufeng (Contributor), Succi, Marc David (Contributor), Traverso, Carlo Giovanni (Contributor), Langer, Robert S (Contributor), Karp, Jeffrey Michael (Author)
Other Authors: Harvard University- (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Karp, Jeffrey (Contributor)
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS), 2017-05-30T13:46:45Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items